Joint effect of modifiable risk factors on Parkinson’s disease: a large-scale longitudinal study

Joint effect of modifiable risk factors on Parkinson’s disease: a large-scale longitudinal study

IntroductionPrevious researches have often underestimated the diversity and combined effects of risk factors for Parkinson’s disease (PD). This study aimed to identify how multiple modifiable risk factors collectively impact PD.MethodsThe study included 452,492 participants from the UK Biobank, util...

Full description

Saved in:

Bibliographic Details
Main Authors:	Panlong Li, Xirui Zhu, Min Liu, Yanfeng Wang, Chun Huang, Junwei Sun, Shan Tian, Yuna Li, Yuan Qiao, Junting Yang, Shanshan Cao, Chaohua Cong, Lei Zhao, Jingjing Su, Dandan Tian
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Human Neuroscience
Subjects:	Parkinson’s disease modifiable risk factors population attributable fraction physical measurement lifestyle medical history
Online Access:	https://www.frontiersin.org/articles/10.3389/fnhum.2025.1525248/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Estimating population attributable risk fraction of determinants of pediatric obesity
by: Maryam Yazdi, et al.
Published: (2025-02-01)

The Multifactorial Memory Questionnaire and Quality of Life: A Longitudinal Study in Parkinson’s Disease
by: Emily J. Corti, et al.
Published: (2025-01-01)

Neuroprotective effects of gastrodin in both in vivo and in vitro models of Parkinson's disease: Mechanisms from the perspective of oxidative stress, ferroptosis, and cellular senescence
by: Shanshan Li, et al.
Published: (2025-02-01)

Glycolytic pathways: The hidden regulators in Parkinson's disease
by: Jing Shen, et al.
Published: (2025-02-01)

Tobacco smoking-attributable mortality in Kenya, 2012–2021
by: Lazarus Odeny, et al.
Published: (2024-07-01)

Instrumental balance assessment in Parkinson's disease and parkinsonism. A systematic review with critical appraisal of clinical applications and quality of reporting
by: Andrea Merlo, et al.
Published: (2025-01-01)

Genetic and neurochemical profiles underlying cortical morphometric vulnerability to Parkinson’s disease
by: Su Yan, et al.
Published: (2025-02-01)

From small to tall: breed-varied household pet dogs can be trained to detect Parkinson’s Disease
by: Lisa Holt, et al.
Published: (2024-10-01)

Electroconvulsive treatment of a patient with Parkinson’s disease and moderate depression
by: John Erik Berg
Published: (2011-02-01)

Association between life's essential 8 and Parkinson's disease: a case–control study
by: Jiaxin Fan, et al.
Published: (2025-02-01)

Integration of Therapeutic Components in the Rehabilitation of Patients with Parkinson’s Disease
by: Sonia Viviané Jiménez Carpi, et al.
Published: (2020-06-01)

Use of Acupuncture in the Rehabilitation Treatment of Patients with Parkinson's Disease
by: Julio López Argüelles, et al.
Published: (2023-04-01)

Effects of exercise training on the nigrostriatal glutamatergic pathway and receptor interactions in Parkinson’s disease: a systematic review
by: Shahid Ishaq, et al.
Published: (2025-02-01)

Enfoques sobre anestesia y enfermedad de Parkinson
by: Evangelina Dávila Cabo de Villa
Published: (2021-04-01)

Value of multi-parameter 123I-MIBG scintigraphy in the differential diagnosis of Parkinson’s disease
by: Teng Xue, et al.
Published: (2025-01-01)

Evaluation of compliance and accuracy in Parkinson’s disease motor symptom tracking: a comparative study of digital and traditional paper diaries using a smartphone application (MyParkinson’s)
by: Nazli Durmaz Celik, et al.
Published: (2025-01-01)

Progress of deep brain stimulation for Parkinson's disease
by: BAI Yu⁃tong, et al.
Published: (2025-01-01)

Genetic screening of South African families with Parkinson’s disease
by: S Bardien, et al.
Published: (2024-02-01)

Aberrant functional connectome gradient and its neurotransmitter basis in Parkinson's disease
by: Tao Guo, et al.
Published: (2025-03-01)

Cancer Burden Disease Attributable to PM2.5 and Health Risk by PM2.5-bound Toxic Species in Two Urban Chilean Municipalities
by: Ye Li, et al.
Published: (2022-11-01)

Gamma knife thalamotomy for essential and Parkinson’s tremor
by: A. Radžiūnas, et al.
Published: (2021-03-01)

Bidirectional relationship between depression and activities of daily living and longitudinal mediation of cognitive function in patients with Parkinson’s disease
by: Yue Xu, et al.
Published: (2025-02-01)

The Role of AMPS in Parkinson’s Disease Management: Scoping Review and Meta-Analysis
by: Roberto Tedeschi, et al.
Published: (2024-12-01)

Cannabis oil in treating Parkinson’s disease: improvement of motor and non-motor symptoms: a case report
by: C. T. M. I. Issa, et al.
Published: (2025-01-01)

Ultrasonido transcraneal en el diagnóstico del Parkinson
by: Aniley Martínez González, et al.
Published: (2014-10-01)

Digital dance programs for Parkinson's disease: challenges and opportunities
by: Judith Bek, et al.
Published: (2025-01-01)

Parkinson’s disease and exosomes: from pathogenesis to diagnosis and treatment
by: A. Mišeikaitė, et al.
Published: (2021-06-01)

The Microbiome-Gut-Brain Axis, Nutrition and Parkinson’s Disease
by: Jevgenija Guk, et al.
Published: (2024-03-01)

Contribution of integrase inhibitor use, body mass index, physical activity and caloric intake to weight gain in people living with HIV
by: Giovanni Guaraldi, et al.
Published: (2023-12-01)

Gene networks and metabolomic screening analysis revealed specific pathways of amino acid and acylcarnitine profile alterations in blood plasma of patients with Parkinson’s disease and vascular parkinsonism
by: A. A. Makarova, et al.
Published: (2025-01-01)

Oxidative stress and dysregulated long noncoding RNAs in the pathogenesis of Parkinson’s disease
by: Jialu Wang, et al.
Published: (2025-01-01)

The Role of Virtual Reality in Postural Rehabilitation for Patients with Parkinson’s Disease: A Scoping Review
by: Francesco Agostini, et al.
Published: (2024-12-01)

Astaxanthin-loaded brain-permeable liposomes for Parkinson’s disease treatment via antioxidant and anti-inflammatory responses
by: Thai-Duong Nguyen, et al.
Published: (2025-02-01)

The Prevalence of Depression Among Parkinson’s Disease Patients in Saudi Arabia: A Cross-Sectional Study
by: Al-Qahtani Z, et al.
Published: (2025-02-01)

In silico analysis of hub genes and regulatory networks implicates the putamen in non-motor Parkinson’s disease disorders
by: Stephen Tunmise Akanbi, et al.
Published: (2025-01-01)

Psychosis in Parkinson's disease in a Southeast Asian cohort: prevalence and clinical correlates
by: Vanessa Wai Ling Mok, et al.
Published: (2022-12-01)

Machine learning and AI for advancing Parkinson's disease diagnosis: exploring promising applications
by: Shohreh Abdollahi, et al.
Published: (2024-03-01)

Pharmacomicrobiomics: a new field contributing to optimizing drug therapy in Parkinson’s disease
by: Yi Zhang, et al.
Published: (2025-12-01)

Biomechanics Parameters of Gait Analysis to Characterize Parkinson’s Disease: A Scoping Review
by: Michela Russo, et al.
Published: (2025-01-01)

Enhanced bioavailability of Quercetin-loaded niosomal in situ gel for the management of Parkinson’s disease
by: Abhishek A. Revankar, et al.
Published: (2025-01-01)